Cover Image

SHR‐1703, a novel long‐acting anti‐interleukin‐5 monoclonal antibody, in asthma patients: A randomized, double‐blind, placebo‐controlled phase 1 study

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Ling Yang, Lixiu He, Yajun Zhang, Meng Fu, Xiaotong Li, Zhu Luo
Format:	Artículo Open Access
Published:	Wiley 2026
Subjects:	British Journal of Clinical Pharmacology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Safety, tolerability, pharmacokinetics and pharmacodynamics of HSK31858, a novel oral dipeptidyl peptidase‐1 inhibitor, in healthy volunteers: An integrated phase 1, randomized, double‐blind, placebo‐controlled, single‐ and multiple‐ascending dose study
by: Yuhao Wang, et al.
Published: (2025)

Effects of intraoperative low‐dose esketamine on postoperative pain after vestibular schwannoma resection: A prospective randomized, double‐blind, placebo‐controlled study
by: Kaizheng Chen, et al.
Published: (2024)

Mild psoriasis as a suitable model for proof‐of‐mechanism in a phase 1B setting: Results from a double‐blind placebo‐controlled trial with guselkumab
by: Jannik Rousel, et al.
Published: (2025)

Effects of a pro‐resolving drug in COVID‐19: preclinical studies to a randomized, placebo‐controlled, phase Ib/IIa trial in hospitalized patients
by: Pedro R. J. Almeida, et al.
Published: (2024)

Antiviral activity, safety and PK/PD of ACC017 in antiretroviral naïve HIV‐infected adults: A randomized, double‐blind, placebo/dose‐parallel‐controlled short‐term monotherapy study
by: N. Han, et al.
Published: (2025)

Preclinical pharmacokinetics of novel long‐acting tenofovir alafenamide/bictegravir solid injectable in rats
Published: (2024)

Development of a population pharmacokinetic model for the novel long‐acting injectable antipsychotic risperidone ISM®
by: Christian Laveille, et al.
Published: (2024)

A randomized, double‐blind study to compare the efficacy and safety of nalbuphine nasal spray and injectable solution in patients after orthopaedic interventions and traumatological procedures
by: Volodymyr G. Tymko, et al.
Published: (2024)

Development of a long‐acting relaxin for the treatment of pulmonary hypertension
by: John Diener, et al.
Published: (2026)

Acute myocardial mechanical responses to colloid and crystalloid volume loading: A randomized double‐blind crossover study
by: Nidhal Bouchahda, et al.
Published: (2026)

The anti‐fibrotic effects of novel heart failure pharmacotherapies in advanced heart failure patients
by: Dávid Nagy, et al.
Published: (2025)

Adverse events associated with monoclonal antibodies used for treatment of COVID‐19: A systematic review and meta‐analysis
by: Htet Htet, et al.
Published: (2025)

Preclinical and translational pharmacology of afucosylated anti‐CCR8 antibody for depletion of tumour‐infiltrating regulatory T cells
by: Gautham Gampa, et al.
Published: (2024)

Amylin analogues as a novel perspective in anti‐obesity therapy
by: Thomas A. Lutz
Published: (2026)

Pharmacokinetics of long‐acting cabotegravir and rilpivirine in seminal plasma throughout the dosing interval
by: N. Neverette, et al.
Published: (2025)

Physiologically‐based pharmacokinetic modelling of long‐acting injectable cabotegravir and rilpivirine in pregnancy
by: Shakir Atoyebi, et al.
Published: (2024)

First‐in‐human assessment of safety and pharmacokinetics of EP9001A:an anti‐nerve growth factor antibody for chronic pain treatment
by: Yue Cheng, et al.
Published: (2025)

R2R01: A long‐acting single‐chain peptide agonist of RXFP1 for renal and cardiovascular diseases
by: Bruno Poirier, et al.
Published: (2024)

AZD0449, an inhaled JAK1 inhibitor, in healthy participants and patients with mild asthma
by: Anna Lundahl, et al.
Published: (2025)

Systemic EP4 receptor agonist and Arginase‐1 therapy in a murine model of chronic asthma and influenza virus‐induced asthma exacerbation
by: Tim Lange, et al.
Published: (2025)

Effects of vaccines targeting interleukin‐1 receptor, type I on atrial and ventricular function after myocardial infarction
by: Jianwu Huang, et al.
Published: (2026)

Pharmacological inhibition of the interleukin‐1 receptor‐associated kinase prevents angiotensin II‐induced cardiac remodelling in mice
by: Shreya Jaiswal, et al.
Published: (2026)

Inter‐ and intraindividual variability of long‐acting cabotegravir/rilpivirine pharmacokinetics after 1 year of continuous use
by: S. Sunagawa, et al.
Published: (2025)

Clinical pharmacology considerations and drug–drug interactions with long‐acting cabotegravir and rilpivirine relevant to sub‐Saharan Africa
by: Adrian Steulet, et al.
Published: (2024)

Cathepsins: Novel opportunities for antibody therapeutics in cancer
by: Timothée David, et al.
Published: (2025)

Airway epithelial overexpressed cathepsin K induces airway remodelling through epithelial–mesenchymal trophic unit activation in asthma
by: Ling Qin, et al.
Published: (2024)

A novel synthesised STAT3 inhibitor exerts potent anti‐tumour activity by inducing lysosome‐dependent cell death
by: Marvin Xuejun Xu, et al.
Published: (2025)

A long‐acting FGF21 attenuates metabolic dysfunction‐associated steatohepatitis‐related fibrosis by modulating NR4A1‐mediated Ly6C phenotypic switch in macrophages
by: Yue Ji, et al.
Published: (2024)

Corticosteroid insensitivity in asthma associated with obstructive sleep apnoea: Role of oxidative stress and histone acetylation
by: Chun‐Yu Lo, et al.
Published: (2025)

Relevance of selected pharmacogenetic polymorphisms to bleeding and thromboembolic risks in Chinese patients taking direct‐acting oral anticoagulants
by: Dongxu Wang, et al.
Published: (2025)

Correction to ‘Sphingosine‐1‐phosphate/TGF‐β axis drives epithelial mesenchymal transition in asthma‐like disease’
Published: (2024)

Intranasal vitamin B12 administration in elderly patients: A randomized controlled comparison of two dosage regimens
by: Monique P. H. Tillemans, et al.
Published: (2024)

Safety, tolerability and pharmacokinetics of DNDI‐6148, a novel agent for leishmaniasis: A randomized, controlled, single ascending dose study in healthy participants
by: Jean‐Yves Gillon, et al.
Published: (2025)

Pentagalloylglucose, a limited oral bioavailability polyphenol, improves allergic asthma through regulating gut microbiota and modulating enteritis
by: Xia'nan Sang, et al.
Published: (2026)

Sevoflurane acts as an antidepressant by suppression of GluN2D‐containing NMDA receptors on interneurons
by: Fei Guo, et al.
Published: (2024)

Efficacy of low dose colchicine on left ventricular hypertrophy in patients with coronary artery disease: A randomized controlled trial
by: Ply Chichareon, et al.
Published: (2026)

Efficacy of low‐dose colchicine on left ventricular hypertrophy in patients with coronary artery disease: A randomized controlled trial
by: Haigu Ke, et al.
Published: (2026)

Multivalent antibody‐based conjugates as new tools for tailored modulation of G protein–coupled receptors
by: Shivani Sachdev, et al.
Published: (2026)

Early clinical pharmacology evaluation of the novel anti‐inflammatory macrolide, glasmacinal (EP395): tolerability, pharmacokinetics and drug interactions
by: Dave Singh, et al.
Published: (2026)

Butyrate acts as a positive allosteric modulator of the 5‐HT transporter to decrease availability of 5‐HT in the ileum
by: Jieling Cai, et al.
Published: (2024)